The stock price of Zimmer Biomet Holdings Inc (NYSE: ZBH) has jumped by 0.49 compared to previous close of 92.34. Despite this, the company has seen a gain of 2.86% in its stock price over the last five trading days. zacks.com reported 2025-06-04 that Zimmer (ZBH) reported earnings 30 days ago. What’s next for the stock?
Is It Worth Investing in Zimmer Biomet Holdings Inc (NYSE: ZBH) Right Now?
The price-to-earnings ratio for Zimmer Biomet Holdings Inc (NYSE: ZBH) is 20.56x, which is above its average ratio. Moreover, the 36-month beta value for ZBH is 0.72. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 6 as “overweight,” 17 as “hold,” and 1 as “sell.”
The public float for ZBH is 197.58M and currently, short sellers hold a 2.79% of that float. On June 26, 2025, ZBH’s average trading volume was 2.29M shares.
ZBH’s Market Performance
The stock of Zimmer Biomet Holdings Inc (ZBH) has seen a 2.86% increase in the past week, with a 0.16% rise in the past month, and a -15.94% fall in the past quarter. The volatility ratio for the week is 0.27%, and the volatility levels for the past 30 days are at 1.22% for ZBH. The simple moving average for the past 20 days is 0.65% for ZBH’s stock, with a -10.85% simple moving average for the past 200 days.
Analysts’ Opinion of ZBH
Many brokerage firms have already submitted their reports for ZBH stocks, with JP Morgan repeating the rating for ZBH by listing it as a “Overweight.” The predicted price for ZBH in the upcoming period, according to JP Morgan is $128 based on the research report published on December 17, 2024 of the previous year 2024.
Piper Sandler gave a rating of “Neutral” to ZBH, setting the target price at $115 in the report published on July 01st of the previous year.
ZBH Trading at -2.53% from the 50-Day Moving Average
After a stumble in the market that brought ZBH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.50% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZBH starting from Yi Sang, who sale 800 shares at the price of $92.51 back on Jun 13 ’25. After this action, Yi Sang now owns 19,624 shares of Zimmer Biomet Holdings Inc, valued at $74,011 using the latest closing price.
Yi Sang, the Group President, Asia Pacific of Zimmer Biomet Holdings Inc, sale 1,000 shares at $95.00 during a trade that took place back on Jun 11 ’25, which means that Yi Sang is holding 20,424 shares at $95,000 based on the most recent closing price.
Stock Fundamentals for ZBH
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.71 for the gross margin
The net margin for Zimmer Biomet Holdings Inc stands at 0.12. The total capital return value is set at 0.07. Equity return is now at value 7.31, with 4.19 for asset returns.
Based on Zimmer Biomet Holdings Inc (ZBH), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at 0.58. The interest coverage ratio of the stock is 5.62.
Currently, EBITDA for the company is 2.25 billion with net debt to EBITDA at 2.52. When we switch over and look at the enterprise to sales, we see a ratio of 3.14. The receivables turnover for the company is 5.02for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.44.
Conclusion
To wrap up, the performance of Zimmer Biomet Holdings Inc (ZBH) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
